U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 9

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:174123399
GRCh38:
Chr2:173258671
MAP3K20, MAP3K20-AS1not provided, Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome
Benign
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr2:174094500
GRCh38:
Chr2:173229772
MAP3K20, MAP3K20-AS1Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome, not provided
Benign
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr2:174128513
GRCh38:
Chr2:173263785
MAP3K20, MAP3K20-AS1S531LMyopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome, not provided
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr2:174055731
GRCh38:
Chr2:173191003
MAP3K20Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome, not provided
Benign
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr2:174123409-174123414
GRCh38:
Chr2:173258681-173258686
MAP3K20, MAP3K20-AS1not provided, Myopathy, centronuclear, 6, with fiber-type disproportion, Split-foot malformation-mesoaxial polydactyly syndrome
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr2:174068513
GRCh38:
Chr2:173203785
MAP3K20-AS1, MAP3K20Split-foot malformation-mesoaxial polydactyly syndrome, Myopathy, centronuclear, 6, with fiber-type disproportion, not provided
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr2:174047614-174047615
GRCh38:
Chr2:173182886-173182887
MAP3K20N95*Myopathy, centronuclear, 6, with fiber-type disproportionPathogenic
(Nov 7, 2017)
no assertion criteria provided
8.
GRCh37:
Chr2:174055838
GRCh38:
Chr2:173191110
MAP3K20W172*not providedPathogenic
(Jun 19, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr2:174055813-174055814
GRCh38:
Chr2:173191085-173191086
MAP3K20M164fsMyopathy, centronuclear, 6, with fiber-type disproportionPathogenic
(Nov 7, 2017)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination